With Government Support, China Medical City Looks To Separate Itself From The Pack
This article was originally published in PharmAsia News
Executive Summary
NEW YORK - Perhaps the largest hurdle China Medical City faces with a U.S. audience is explaining how it differs from China's more established science and technology parks like Zhangjiang Hi Tech Park in Shanghai, Zhong-guan-cun Life Science Park in Beijing and BioBay in Suzhou
You may also be interested in...
Emerging Company In An Emerging Market: Generon Sees Quality And Price As Litmus Test
Generon in Shanghai was founded by former Hutchison MediPharma employees to target a niche market between expensive import drugs and lower quality domestic products.
Pharmaceutical Investment, Expansion Driving Up Real Estate Prices In Asia
One of the largest industrial estates in Southeast Asia is in Cikarang, West Java, Indonesia. It and dozens of clusters are fueling a realignment of the global pharmaceutical industry and pushing up real estate prices across Asia.